Showing 461-470 of 1365 results for "".
Optimizing Acne Treatment: The Importance of the First Follow-up
https://practicaldermatology.com/topics/general-topics/optimizing-acne-treatment-the-importance-of-the-first-follow-up/20972/The first follow-up visit is a time to measure efficacy and compliance, reinforce key messages, make adjustments to the regimen, and discuss acne sequela.Starting a Practice: Choosing Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/starting-a-practice-choosing-devices/18900/In his new series for Modern Aesthetics® Magazine, Christopher Khorsandi, MD offers tips for aesthetic physicians opening or expanding a practice. In this edition he discusses device selection and integration with an emphasis on marketing and patient conversion.Skin cancer: Coach's toughest opponent [Full-length]
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-coach-s-toughest-opponent-full-length-/18921/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The PSA and video feature Division I college women's basketball coach Lisa Pace, who blames her indoor tanning habit for the development of more than 80 skin cancers, five ofSkin cancer: Coach's toughest opponent: PSA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-coach-s-toughest-opponent-psa/18922/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The PSA and video feature Division I college women's basketball coach Lisa Pace, who blames her indoor tanning habit for the development of more than 80 skin cancers, five ofGuys, Don't Be Like Paul:Â PSA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/guys-don-t-be-like-paul-psa/18924/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The first PSA and video focuses specifically on men and features Dr. Keaney. Data from the Skin Cancer Foundation cited by ASDS show that only 30 percent of American men areA User's Guide to the Field of Biologic Therapies
https://practicaldermatology.com/topics/psoriasis/PD0709_01-php/22796/All the facts you need to know about available biologic therapies, assembled in one place.Expanded Options in Adjuvant Immunotherapy for Resectable Melanoma: A Multidisciplinary Conversation
https://practicaldermatology.com/programs/cme/expanded-options-in-adjuvant-immunotherapy-for-resectable-melanoma-a-multidisciplinary-conversation/18065/Tune in to learn best practices for using adjuvant systemic therapy and appropriate agents for stage IIB-IV resectable melanoma patients.DermWireTV: SPF Accuracy, Dupixent PN Data, AD Pipeline
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spf-accuracy-dupixent-pn-data-ad-pipeline/20009/Researchers from the Environmental Working Group say that many sunscreens offer less than half their stated SPF protection against UVB. The Thriving in Aesthetics educational series featuring Sabrina Fabi, MD and Steven Dayan, MD is returning with a focus on diversity in aesthetics. As eczema awareSkin Reactions: Understanding New Drug Adverse Effects
https://practicaldermatology.com/conferences/aad-summer-2021/skin-reactions-understanding-new-drug-adverse-effects/19975/In addition to needing to stay abreast of new drugs in dermatology, it's important for dermatologists to stay informed about new medications that come to market in general. Vinod Nambudiri, MD, MBA says there are often dermatology-related adverse events that need to be managed. He discusses new cancApproval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by heal